BBAGF (BB Biotech AG) Total Current Assets: $ Mil (As of Mar. 2026)


BBAGF BB Biotech AG BBAGF
15 GF Score
Price $76.06
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Total Current Assets?

BB Biotech AG BBAGF -29.53% 15 Total Current Assets is $ Mil as of Mar. 2026. GuruFocus rates BBAGF with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Total Current Assets does not apply to banks and insurance companies.

BBAGF
15GF Score
BB Biotech AG BBAGF
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $ Mil mean?
BB Biotech AG (BBAGF) has a Total Current Assets of $ Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for BB Biotech AG and its competitors.
Is BB Biotech AG's Total Current Assets too high?
BB Biotech AG's current Total Current Assets is $ Mil. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Total Current Assets compare to VRTX and REGN?
BB Biotech AG's Total Current Assets of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for BB Biotech AG and its competitors. BB Biotech AG's current Total Current Assets is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (BBAGF) has a current Total Current Assets of $ Mil. The current Total Current Assets is $ Mil. BB Biotech AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For BB Biotech AG (BBAGF), the current Total Current Assets is $ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for BBAGF

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.06
Price